ISSN# 1545-4428 | Published date: 19 April, 2024
You must be logged in to view entire program, abstracts, and syllabi
At-A-Glance Session Detail
   
Parkinson's Disease II
Digital Poster
Neuro
Thursday, 09 May 2024
Exhibition Hall (Hall 403)
09:15 -  10:15
Session Number: D-130
No CME/CE Credit

Computer #
4374.
49Perfusion dynamics in a mouse line of Parkinson’s Disease
Sara Pires Monteiro1,2, Ruxanda Lungu Baião1, Lydiane Hirschler3, Emmanuel L. Barbier4, Patrícia Figueiredo2, and Noam Shemesh1
1Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal, 2Institute for Systems and Robotics - Lisboa and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal, 3C.J. Gorter Center for High Field MRI, Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Université Grenoble Alpes, Inserm, Grenoble Institut des Neurosciences, Grenoble, France

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: Parkinson disease patients show alterations in their vascular system, exhibiting lower perfusion than healthy subjects.

Goal(s): Here, we harness a mouse model exhibiting extensive human α-syn deposition to investigate cerebral blood flow properties in PD. 

Approach: We use a novel setup enabling high resolution Pseudo-Continuous Arterial Spin Labelling, a non-invasive technique for perfusion mapping in-vivo without injection of contrast agentes.

Results: We found that not only the PD mouse line but also their WT littermates have altered perfusion properties across the brain compared to control c57bl/6 mice.
 
 

Impact: Our findings highlight the importance of accounting for these potential sources of variability in future work with these lines.

4375.
50Putaminal spontaneous activity characterizes and predicts wearing-off in Parkinson’s disease
Chenqing Wu1, Haoting Wu1, Xiaojun Guan1, Xiaojun Xu1, and Minming Zhang1
1The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: Delayed detection of wearing off (WO) in Parkinson’s disease (PD) has a negative impact on quality of life. However, there is currently no method for WO prediction prior to treatment.  

Goal(s): To investigate whether resting-state functional MRI (rs-fMRI) could aid in WO prediction.

Approach: Fractional amplitude of low-frequency fluctuation (fALFF) was quantified from rs-fMRI to determine whether spontaneous activity dysfunction could be a predisposing vulnerability related to WO.

Results: Putaminal fALFF reduction was the independent predictor of WO development.

Impact: Detection of putaminal fALFF reduction prior to treatment provides a quantitative metric to facilitate WO prediction and improve prognosis.

4376.
51Gender-Specific Brain Morphological and Network Differences in Parkinson's Disease Patients with Rapid Eye Movement Sleep Behavior Disorder
Yang Liu1,2,3, Pengfei Zhang1,2,3, Kai Ai4, Yan Li Jiang1,2,3, Guangyao Liu1,2,3, and Jing Zhang1,2,3
1Second Clinical School, Lanzhou University, lanzhou, China, 2Department of Magnetic Resonance, Lanzhou University Second Hospital, lanzhou, China, 3Gansu Province Clinical Research Center for Functional and Molecular Imaging, lanzhou, China, 4Philips Healthcare, Xi’an, China

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: The influence of gender on the brain morphology of PD-RBD patients remains unclear. 

Goal(s): We aimed to investigate gender differences in PD-RBD patients in terms of cortical morphology and individual structural covariance network.

Approach: We firstly conducted volume- and surface-based morphometry analyses, followed by further exploration of the topological characteristics of individual level morphological similarity networks based on Kullback-Leibler Divergence.

Results: Male patients presented decreased cortical indicators in salience, along with increased volume, cortical complexity and sulcus depth increase. Furthermore, in the individual morphological networks, we found significant differences between male and female patients in terms of both global and nodal properties.

Impact: PD-RBD patients exhibit significantly gender-specific differences in brain morphology and covariant patterns, which may reflect distinct clinical treatment needs and disease progression patterns. Further exploration is needed to enhance clinical management efficiency.

4377.
52Abnormalities of brain functional network in Parkinson’s disease at different stage
Xinhui Wang1, Yu Shen1, Kaiyue Ding2, Yihang Zhou3, Wei Wei1, Yan Bai1, Xianchang Zhang4, Zhiping Guo5, and Meiyun Wang1
1Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China, 2Henan University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China, 3Xinxiang Medical University & Henan Provincial People’s Hospital, Zhengzhou, China, 4MR Research Collaboration, Siemens Healthineers Ltd., Beijing, China, 5Zhengzhou University People’s Hospital & FuWai Central China Cardiovascular Hospital, Zhengzhou, China

Keywords: Parkinson's Disease, Brain Connectivity, Parkinson's disease, fMRI

Motivation: Currently there are no effective non-invasive neuroimaging biomarkers to evaluate the progression of Parkinson's disease (PD).

Goal(s): To use graph theory analysis of resting-state functional MRI (rs-fMRI) to investigate the abnormalities of brain functional network in PD at different disease stages.

Approach: We evaluated the global and nodal indicators changes between PD at different disease stages by comparison with healthy control.

Results: Brain functional network topology was disrupted to a varying extent in patients with PD at different disease stages.

Impact: The findings of this study may enhance our understanding of the mechanisms underlying the progression of Parkinson's disease and contribute to the development of non-invasive neuroimaging biomarkers for monitoring disease progression.

4378.
53Utilizing synthetic MRI and brain regional analysis for early Parkinson's disease diagnosis
Gang Zhang1, Miao Chen1, Wenjia Wang2, Lizhi Xie2, and Rui Zhang1
1hulunbuir people’s hospital, Hulunbuir, China, 2MR Research China, GE HealthCare, Beijing, China

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: Early detection of Parkinson's disease (PD) is crucial, and MRI has been a valuable tool. Synthetic MRI, allows for comprehensive analysis of brain regions, offering potential for early diagnosis.

Goal(s): Evaluate the feasibility of synthetic MRI in early PD diagnosis by studying brain regions.

Approach: 31 PD patients and 25 controls underwent MRI. Synthetic MRI provided T1, T2, and PrD maps. Brain regions were analyzed and a combined diagnostic model was developed.

Results: Differences in T1 and T2 values were found in the calcarine, cuneus, and hippocampus. The model achieved an AUC of 0.930, suggesting synthetic MRI-derived parameters can serve as  biomarkers.

Impact: The combined diagnosis using T1 and T2 values in specific brain regions effectively distinguished early-stage Parkinson's disease (ESP) from healthy controls (HC). This suggests that synthetic MRI-derived parameters have the potential to serve as precise early PD diagnostic biomarkers.

4379.
54Association of glymphatic system impairment with aging and cognitive decline in Parkinson's disease
Yang Zhao1, Changyuan Xu2, Yufan Chen2, Mengyuan Zhuo3, Yuxin Li1, Weibo Chen4, Tao Gong1, and Guangbin Wang1
1Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, 2Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, 3Department of Radiology, Shandong University, Jinan, China, 4Philips Healthcare, Shanghai, China

Keywords: Parkinson's Disease, Parkinson's Disease, glymphatic system

Motivation: In this study,we aimed to investigate the activity of the glymphatic system in PD using DTI-ALPS method and to further explore the correlation patterns of DTI-ALPS indexes with aging and cognitive impairment.

Goal(s): To explores the correlation between glymphatic system impairment and cognitive impairment.

Approach: Diffusion tensor image analysis along the perivascular space (DTI-ALPS) index offers a noninvasive alternative and the method has been validated well with standard glymphatic MRI.

Results: Our study found that glymphatic system function was impaired in PD as reflected by DTI-ALPS. Glymphatic dysfunction may lead to cognitive impairment,which was affected by aging and disease state.

Impact: Our study explores the correlation between glymphatic system impairment and cognitive impairment.This finding provides new perspectives on cognitive impairment in patients with PD and suggests potential strategies for treating cognitive impairment in such patients.

4380.
55Iron deposition of basal ganglia on 7 Tesla MRI for diagnosis of early-stage Parkinson’s disease
Jianing Jin1,2, Dongning Su1, Zhe Zhang3, Jing Jing3, Yuan Li4, and Tao Feng1
1Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2China National Clinical Research Center for Neurological Diseases, Beijing, China, 3Tiantan Neuroimaging Center of Excellence, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 4MR Research Collaboration Team, Siemens Healthineers, Beijing, China

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: Early diagnosis of Parkinson's disease (PD) remains challenging.

Goal(s): Aimed to identify new imaging features in the basal ganglia of PD by 7T iron-sensitive MRI, and to investigate the diagnostic performance of the new imaging features in distinguishing early-stage PD patients from healthy subjects.

Approach: 129 participants were prospectively recruited between May 2021 and September 2023. All participants were scanned at Tiantan Neuroimaging Center using 7-Tesla MRI. Two neuroradiologist separately evaluated the visual rating scale of iron deposition signs in basal ganglia.

Results: The newly developed basal ganglia sign scoring scale showed high sensitivity and excellent specificity for diagnosis of early-stage PD.

Impact: The distribution characteristics of iron deposition in basal ganglia might be a promising marker of the diagnosis of early-stage PD.

4381.
56AI based neuromelanin MRI analysis in a multi-site longitudinal Parkinson’s Disease study
Madhura Ingalhalikar1, Ha Pham1, Kim Nguyen1, Luc Bracoud2, Matthew Hutchison3, Karleyton C Evans3, Tien Dam3, Joel Schaerer2, Chris Conklin1, Joyce Suhy1, and David Scott1
1Clario., San Mateo, CA, United States, 2Clario., Lyon, France, 3Biogen Inc., Boston, MA, United States

Keywords: Parkinson's Disease, Parkinson's Disease, Neuromelanin contrast MRI, AI, clinical trial, longitudinal

Motivation: Neuromelanin (NM) MRI is a proposed biomarker of dopaminergic neurodegeneration in the substantia nigra pars compacta (SNpc).

Goal(s): To automate post-hoc analysis on NM-MRI data acquired from a large multi-center clinical trial. 

Approach: A deep dynamic u-net model was built to segment the SNpc and the background region automatically and was used to analyze a large multi-center longitudinal PD dataset. 

Results: Within-subject change from baseline effects were significant at the population level for SNpc volume (left and right). These results suggest an AI-derived SNpc volume, estimating the atrophied hyperintense region on an NM-MRI scan, is a viable marker of disease progression in PD.

Impact: The dynamic AI model on NM-MRI trained/tested on multiple sites/scanners accurately and robustly delineates the SNpc and may have applicability in trials where NM-MRI is used as a marker of nigrostriatal degeneration.

4382.
57Mapping of iron deposition gradients in the nigrostriatal system in normal aging and Parkinson's disease
Jiaqi Wen1, Xiaojie Duanmu1, Sijia Tan1, Qianshi Zheng1, Weijin Yuan1, Chenqing Wu1, Jianmei Qin1, Haoting Wu1, Tao Guo1, Cheng Zhou1, Jingjing Wu1, Jingwen Chen1, Yong Zhang2, Minming Zhang1, Xiaojun Guan1, and Xiaojun Xu1
1Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 2GE Healthcare, Shanghai, China

Keywords: Parkinson's Disease, Parkinson's Disease, Normal aging; Gradient; Quantitative susceptibility mapping; Nigrostriatal

Motivation: The gradient characterization of microenvironment in nigrostriatal system is key to understanding striatal dysfunction in PD.

Goal(s): To investigate the gradients of neurodegeneration in nigrostriatal system in normal aging and PD.

Approach: Quantitative susceptibility mapping (QSM) and spatial method were used to detect the spatial gradient of iron deposition in healthy young people, normal elderly and PD in vivo.

Results: During normal aging, iron deposition was significant in almost all segments of the striatum, and iron content was even higher in some segments of the caudate than in PD. Iron deposition in PD is mainly in the central substantia nigra.

Impact: The present study reveals the spatial gradient of iron deposition in the nigrostriatal system in normal aging and PD, providing more subtle and profound insights into the pathological changes in subcortical nuclei during neurodegeneration.

4383.
58A preliminary study on the differences in regional changes of neuromelanin and iron in substantia nigra among early parkinsonism
Yufan Chen1, Changyuan Xu1, Yang Zhao1, Mengyuan Zhuo2, Lijuan Wang3, Weibo Chen4, Tao Gong1, and Guangbin Wang1
1Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, 2Shandong University, Jinan, China, 3Department of Radiology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China, 4Philips Healthcare, Shanghai, China

Keywords: Parkinson's Disease, Parkinson's Disease, neuromelanin

Motivation: Differential diagnosis of parkinsonism is difficult in early stage. Neuromelanin of SN plays an important role in the development of PD, PSP and MSA with iron.

Goal(s): To find more neuroimage biomarkers to differentiate early parkinsonism by altered neuromelanin and iron in the level of SN subregions.

Approach: We applied the 3D-ME-MTC-NM sequence to differentiate subregions based on the distribution of neuromelanin and iron, measured the volume, CR and/or susceptibility of neuromelanin accumulation, iron deposition and overlap regions.

Results: The susceptibility of overlap region increased in early PSP, while no significant difference was seen between PD and MSA. 

Impact: The alteration of susceptibility in the overlap region may be helpful to identify characteristic changes in parkinsonism via different pathological proteins.

4384.
59Accuracy of AI-driven susceptibility map-weighted MRI analyses to differentiate neurodegenerative from non-neurodegenerative parkinsonism
Elon D. Wallert1, Elsmarieke van de Giessen2, Martijn Beudel3, Dong Hoon Shin4,5, Tom van Mierlo6, Jeroen Blankevoort7, Henk W. Berendse8, Rob M.A. de Bie3, and Jan Booij1
1Department of Radiology and Nuclear medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, 2Department of Radiology and Nuclear medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands, 3Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands, 4'Heuron Co., Ltd., Seoul, Korea, Republic of, 5Department of Neurology, Gachon University College of Medicine, Incheon, Korea, Republic of, 6Department of Neurology, Spaarne Gasthuis, Haarlem, Netherlands, 7Department of Neurology, Flevoziekenhuis, Almere, Netherlands, 8Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: Susceptibility map-weighted imaging (SMWI) of the substantia nigra is a novel MRI sequence that has the potential to aid the diagnosis of patients with clinically uncertain parkinsonian syndromes (CUPS).

Goal(s): To investigate the accuracy of AI-driven automated SMWI software in a clinically relevant population.

Approach: We acquired SMWI in patients who received a dopamine transporter (DAT)-SPECT because of CUPS. The diagnostic software (Heuron IPD) results were compared with the DAT-SPECT results as a reference. 

Results: Preliminary analysis of 120 patients demonstrated an accuracy of 88% for the diagnostic software to differentiate neurodegenerative from non-neurodegenerative parkinsonism in patients who presented with CUPS.

Impact: Susceptibility map-weighted imaging (SMWI) demonstrates a diagnostic accuracy of 88% in patients with clinically uncertain parkinsonian syndromes (CUPS). These findings are promising for the use of SWMI as diagnostic marker and warrant prospective studies in CUPS patients.

4385.
60Arterial spin labeling-based machine learning for idiopathic rapid eye movement sleep behavior disorder and Parkinson's disease
Mingshen Chen1, Yuqi Zhi2, Huihui Lin2, Yiwen Xu2, Tong Chen2, Xiaoyu Cheng3, Chengjie Mao3, Zhen Jiang2, Xiaoyun Liang4,5, Yunzhu Wu6, Bo Peng1, Yakang Dai1, and Jiangtao Zhu2
1Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, People’s Republic of China, suzhou, China, 2Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People’s Republic of China, suzhou, China, 3Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People’s Republic of China, suzhou, China, 4Institute of Artificial Intelligence and Clinical Innovation, Neusoft Medical Systems Co., Ltd., Shanghai, People’s Republic of China, shanghai, China, 5Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia, Melbourne, Australia, 6MR Research Collaboration Team, Siemens Healthineers Ltd. Shanghai, China., shanghai, China

Keywords: Parkinson's Disease, Arterial spin labelling, Neurodegenration, Neuroscience

Motivation: Investigating cerebral blood flow (CBF) alterations between idiopathic REM sleep behavior disorder (iRBD) and Parkinson's disease (PD) using arterial spin labeling (ASL) can provide crucial insights into the shared neurobiological underpinnings of these conditions, facilitating effective disease management and treatment.

Goal(s): Analyzing the cerebral blood flow (CBF) variations and CBF-connectivity and evaluating their diagnostic utility.

Approach: By employing ASL, we conducted a detailed analysis of CBF variations and constructed a CBF-connectivity network. 

Results: Observed increased CBF in PD vs iRBD in specific regions, as well as elevated connectivity.

Impact: The present study provides objective biomarkers for the progression of iRBD and PD through the study of cerebral perfusion. It also provides direction for adjunctive treatment of microcirculatory abnormalities to further inhibit the progression of associated dysfunction.

4386.
61MEGA-PRESS Detects the Changes of Metabolite in Parkinson's Disease with Depression
Xinzi Liu1, jinyue Xue1, Yongzhou Xu2, Lu Han3, and Zhibo Wen1
1Zhujiang Hospital, Southern Medical, Guangzhou, China, 2Philips Healthcare, Guangzhou, China, Guangzhou, China, 3Philips Healthcare, Shanghai, China, Shanghai, China

Keywords: Parkinson's Disease, Quantitative Imaging, MEGA-PRESS

Motivation: Altered λ-aminobutyric acid (GABA) levels have been observed in Parkinson's disease (PD), and these discrepancies may depend in differences of clinical symptoms. However, the role o GABA and glutamate concentrations of depression in Parkinson's disease (DPD) remains unexplored.

Goal(s): To explore the changes of GABA+, glutamate and glutamate (Glx) in DPD.

Approach: We utilized MEGA-PRESS to measure GABA+ and Glx levels in the medial frontal cortex (MFC) and thalamus among PD patients with and without depression, along with aged-matched healthy participants.

Results: GABA+ levels were found to be elevated within MFC in individuals with DPD, independent of the presence of Parkinson’s disease.

Impact: These findings suggest that GABAergic alterations in specific brain regions might be linked to the clinical symptoms of PD. Modulating GABAergic function could be a potential approach for treating DPD.

4387.
62Association of Asian Parkinson's Disease risk variant rs9638616 with brain structural and functional changes
Thomas Welton1 and Thomas Teo2
1Research, National Neuroscience Institute; Duke-NUS Medical School, Singapore, Singapore, Singapore, 2Research, National Neuroscience Institute, Singapore, Singapore

Keywords: Parkinson's Disease, Diffusion Tensor Imaging

Motivation: The genetic variant rs9638616, is associated with Parkinson’s Disease (PD) risk in Asian populations.

Goal(s): To provide insight into the neural correlates of rs9638616 in Asian PD, to inform risk models and idiopathic PD aetiology.

Approach: Using imaging and genotyping data from 116 early-PD patients and 57 controls of Chinese ethnicity, we performed voxelwise analyses to assess rs9638616 T-allele association with brain microstructure, morphology and function.

Results: Our results suggest that rs9638616 may confer PD risk in Asian cohorts via lower white matter fractional anisotropy and reduced supplementary motor area functional connectivity.

Impact: In an imaging-genetics analysis, the Asian PD risk variant rs9638616 was associated with altered brain structure/function. This rationalises rs9638616’s role in PD risk, and may be useful in improving PD stratification and risk modeling.

4388.
63Dorsal nigral hyperintensity abnormality in 7T MRI is a biomarker for diagnosis of Parkinson’s disease and atypical parkinsonisms
Dongning Su1, Zhijin Zhang1, Zhe Zhang2, Rui Yan1, Wanlin Zhu2, Ning Wei2, Yue Suo2, Xinyao Liu2, Huiqing Zhao1, Zhan Wang1, Huizi Ma1, Junhong Zhou3, Joyce S. T. Lam4, Yuan Li5, Tao Wu1, Jing Jing2, and Tao Feng1
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 2Tiantan Neuroimaging Center of Excellence, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 3Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA, United States, 4Pacific Parkinson’s Research Centre, Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada, 5MR Research Collaboration Team, Siemens Healthineers, Beijing, China

Keywords: Parkinson's Disease, Parkinson's Disease, 7T MRI; dorsal nigral hyperintensity

Motivation: The dorsal nigral hyperintensity (DNH) abnormality is a characteristic feature of PD and 7T MRI has proved useful for its  visualization.

Goal(s): To investigate the diagnostic efficiency of DNH abnormality at different stages of PD and in atypical parkinsonisms using 7T MRI.

Approach: PD, RBD, MSA-P, MSA-C, and PSP patients and controls underwent 7T T2* with DNH abnormality assessed for diagnostic performance. R2* mapping and principal component analysis were performed in substantia nigra.

Results: MSA-C and RBD demonstrated higher preservation rate of DNH than PD, MSA-P, and PSP. DNH scoring criteria proved an optimal diagnostic method of PD, RBD, MSA-P, MSA-C, and PSP.

Impact: MSA-C and RBD patients had higher dorsal nigral hyperintensity (DNH) preservation rate compared with PD, MSA-P, and PSP. The DNH scoring criteria proved an optimal diagnostic method of PD, RBD, MSA-P, MSA-C, and PSP.

4389.
64Fast SMWI : Optimizing Classifier with FOV reduction simulation
Jonghyo Youn1, Juhyung Park1, Sooyeon Ji1, Jaewoo Choi1, Hwan Heo2, MyeongOh Lee2, Soohwa Song2, Donghoon Shin2, Eung Yeop Kim3, and Jongho Lee1
1Seoul National University, Seoul, Korea, Republic of, 2Heuron Co.Ltd., Seoul, Korea, Republic of, 3Department of Radiology, Samsung Medical Center, Seoul, Korea, Republic of

Keywords: Parkinson's Disease, Parkinson's Disease

Motivation: SMWI is an advanced SWI method capable of detecting nigral hyperintensity in the substantia nigra. Due to the long scan time, a reduced FOV sequence was proposed to decrease the scan time from 4min 15sec to 2min 45sec, along with the application of denoising techniques. However, when evaluated with the original classifier, the results showed changes, reporting increased FN, which may be a problem in clinic.

Goal(s): Maintaining diagnostic results for the reduced FOV with denoised SMWI images.

Approach: Optimizing classifier to denoised FOV-simulated SMWI images.

Results: The diagnostic result of denoised FOV 64.5% SMWI images is comparable to FOV 100% SMWI images.

Impact:  The diagnostic result of denoised FOV 64.5% SMWI images is comparable to FOV 100% SMWI images with the optimizing classifier based on denoised FOV-simulated SMWI images.